Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro.
about
Use of a novel cell-based fusion reporter assay to explore the host range of human respiratory syncytial virus F protein.Unity in diversity: shared mechanism of entry among paramyxovirusesCX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent MannerIn vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivoGlycosaminoglycan sulfation requirements for respiratory syncytial virus infection.Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro.The central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo.Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice.Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with F protein.Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate.Functional Analysis of the 60-Nucleotide Duplication in the Respiratory Syncytial Virus Buenos Aires Strain Attachment Glycoprotein.Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced DiseasesRespiratory syncytial virus infection: from biology to therapy: a perspective.Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimersThe host response and molecular pathogenesis associated with respiratory syncytial virus infection.RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV GHeparan Sulfate Proteoglycan Is an Important Attachment Factor for Cell Entry of Akabane and Schmallenberg Viruses.Preventing Cleavage of the Respiratory Syncytial Virus Attachment Protein in Vero Cells Rescues the Infectivity of Progeny Virus for Primary Human Airway Cultures.Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide.Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G.Echoviruses bind heparan sulfate at the cell surface.Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein geneRespiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact.Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection.Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells.Genetic Stability of Parainfluenza Virus 5-Vectored Human Respiratory Syncytial Virus Vaccine Candidates after In Vitro and In Vivo Passage.
P2860
Q24815873-99E5D371-878C-4DC4-8406-99D7971AD773Q26864825-632065C8-6983-4210-9DFE-BC85029AD36DQ27303940-F09D9720-DC09-4144-BBA6-B6E23B6EB2F9Q30512964-EBCC752D-80E0-4938-878D-90D7BCEAA27FQ33787265-2BE28570-A22E-4B06-A576-8221D9B1C061Q34057989-E124807F-64DE-4222-8FC6-6BF050F10049Q34151865-CC70B455-A4AB-4DB6-B5AA-0DF35E86DA88Q34340452-A6767110-89A9-43E8-B1AE-042953413BD3Q34353365-64A249EE-D53E-47FA-88B7-502128AEE160Q34975477-A47E31FE-BA29-49B8-9FDA-7C2ABF41DEE8Q35634327-36CD0A3D-F631-4257-A16F-A31EB3FC42DEQ35826221-558B1169-BFD8-491A-A58E-3D7A27A0EBFEQ35914372-39D18E8A-BFC1-46BF-8A9B-456EFF468798Q36246429-C13F3613-AE06-4963-86E6-0A6860A11ADFQ36834294-3D4FBF85-D365-436E-AF5E-A7F36A4E3A43Q36879938-C0F5F3BB-55BD-4752-BC28-7BE030EAFC12Q37263779-5F3AF2D5-27A8-4140-A9EA-9FE4FBD0FB47Q37730065-72995FA8-CEFB-4EB4-9D0C-6136877D1E84Q38702374-2A612A88-2183-42CA-BAD6-7CF5D0CB400FQ38941405-8DCACACE-41DF-4A50-B322-5F6A012FC8AAQ39304663-DE006970-1D0B-4B04-8101-C39C1D427797Q39595322-D840B0E3-EB76-4BD4-B205-B97F9F5E5AF6Q39602859-BD2C1CF1-D699-4D41-9F07-9D1EC64B92E2Q39603697-C413C3A5-5128-4AA8-B4C7-D3D6E245C614Q39682220-8B36DA3B-A064-40BB-A579-202144B1BE8EQ39742113-C0961E95-A533-4F89-AA53-76CB977B864DQ39789193-F78BBCF1-0EC0-4071-A5A6-1E82874BA345Q40107054-F3744131-4D64-4A46-A8B7-E2F6D025E689
P2860
Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Heparin-like structures on res ...... d in its infectivity in vitro.
@en
type
label
Heparin-like structures on res ...... d in its infectivity in vitro.
@en
prefLabel
Heparin-like structures on res ...... d in its infectivity in vitro.
@en
P2093
P2860
P1433
P1476
Heparin-like structures on res ...... ed in its infectivity in vitro
@en
P2093
P2860
P304
P407
P577
1998-09-01T00:00:00Z